|
DPM1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.145600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.073370E-01 |
| Normal-vs-Stage2 |
3.587600E-01 |
| Normal-vs-Stage3 |
8.170600E-01 |
| Normal-vs-Stage4 |
4.649400E-01 |
| Stage1-vs-Stage2 |
8.953800E-01 |
| Stage1-vs-Stage3 |
1.711040E-01 |
| Stage1-vs-Stage4 |
8.393600E-01 |
| Stage2-vs-Stage3 |
3.972000E-01 |
| Stage2-vs-Stage4 |
9.214000E-01 |
| Stage3-vs-Stage4 |
5.415800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.814200E-01 |
| Normal-vs-AfricanAmerican |
3.009600E-01 |
| Normal-vs-Asian |
8.189400E-01 |
| Caucasian-vs-AfricanAmerican |
8.046800E-01 |
| Caucasian-vs-Asian |
8.526000E-01 |
| AfricanAmerican-vs-Asian |
7.520600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.175800E-02 |
| Normal-vs-Female |
6.830000E-01 |
| Male-vs-Female |
1.931670E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.480200E-01 |
| Normal-vs-Extreme_Weight |
1.238760E-01 |
| Normal-vs-Obese |
6.486400E-01 |
| Normal-vs-Extreme_Obese |
2.537600E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.459800E-01 |
| Normal_Weight-vs-Obese |
5.183000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.150800E-01 |
| Extreme_Weight-vs-Obese |
3.359400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.482200E-01 |
| Obese-vs-Extreme_Obese |
1.396570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.091000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.409800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.431700E-02 |
| Normal-vs-Age(81-100Yrs) |
1.329740E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.059600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.868100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.076170E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.312550E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.339800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.711600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.522600E-01 |
| Normal-VS-Type2 PRCC |
4.860200E-03 |
| Normal-VS-KIRP CIMP |
3.389200E-01 |
| Normal-VS-Unclassified PRCC |
7.080000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.948310E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.592500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.941000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.105590E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.106200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.467800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.041900E-02 |
| Normal-vs-N1 |
3.470400E-01 |
| Normal-vs-N2 |
9.888000E-02 |
| N0-vs-N1 |
9.361500E-03 |
| N0-vs-N2 |
6.421200E-01 |
| N1-vs-N2 |
1.652430E-01 |
|
|
